₹164.9
■ +0 +0.00%
17 Jul 2026
BSE Listed
Mahamaya Lifesciences Limited (544611)
Volume: 1,200Avg Vol 1W: 6,000Avg Vol 1M: 11,72752W Range:₹111₹205.05
Key Ratios
Checked just nowMarket Cap₹386 Cr
Current Price₹164.9
Previous Close₹164.9
High / Low (52w)₹205.05 / ₹111
Volume1,200
Avg Vol (1W)6,000
Avg Vol (1M)11,727
Stock P/E23.36
Book Value₹52.09
Dividend Yield0%
ROE13.55%
ROA286.7%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding2 Cr
Face Value—
EPS (TTM)₹7.06
P/B3.17
Debt / Equity1.52
50 DMA₹171.53
200 DMA—
Day change+0.00%
Price Chart
₹164.9▲ 43.39% · 1Y
2025-11-182026-07-17
20-day avg volume: 12K shares
Pros
- Company is almost debt-free.
- Revenue grew 64% YoY.
- Net profit is growing year over year.
Profit & Loss (Annual)
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Revenue | ₹90 Cr | ₹137 Cr | ₹163 Cr | ₹267 Cr |
| EBITDA | ₹5 Cr | ₹8 Cr | ₹13 Cr | ₹24 Cr |
| Net Profit | ₹3 Cr | ₹4 Cr | ₹5 Cr | ₹13 Cr |
| EPS | 21.81 | 30.03 | 41.79 | 7.6 |
Balance Sheet
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Total Assets | ₹56 Cr | ₹78 Cr | ₹112 Cr | ₹188 Cr |
| Total Liabilities | ₹40 Cr | ₹58 Cr | ₹87 Cr | ₹139 Cr |
| Equity | ₹16 Cr | ₹19 Cr | ₹25 Cr | ₹49 Cr |
| Total Debt | — | — | — | — |
Cash Flow
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Operating | ₹3 Cr | ₹2 Cr | ₹-21 Cr | ₹3 Cr |
| Investing | ₹-3 Cr | ₹-3 Cr | ₹-2 Cr | ₹-8 Cr |
| Financing | ₹1 Cr | ₹2 Cr | ₹24 Cr | ₹9 Cr |
| Free Cash Flow | ₹3 Cr | ₹2 Cr | ₹-21 Cr | ₹3 Cr |
Shareholding
Promoter 56.35% Institutions 7.3% Public 36.36%
Efficiency & Working Capital
ROCE15.1%
Interest Coverage3.5
Dividend Payout—
Debtor Days67 d
Inventory Days138 d
Payable Days76 d
Cash Conversion Cycle129 d
Working Capital Days205 d
Shareholding Details
As of 2026-03-31
Promoter56.3%
FII4.8%
DII2.5%
Institutions7.3%
Public36.4%
Promoter Pledge0%
No. of Shareholders584
Shareholding Pattern
Quarterly — figures in %. Latest 4 quarters.
| Period | Feb 2025 | Oct 2025 | Nov 2025 | Mar 2026 |
|---|---|---|---|---|
| Promoters | 77.3% | 77.3% | 56.3% | 56.3% |
| FIIs | 0% | 0% | 6.4% | 4.8% |
| DIIs | 0% | 0% | 4.7% | 2.5% |
| Public | 22.7% | 22.7% | 32.6% | 36.4% |
| Promoter Pledge | 0% | 0% | 0% | 0% |
| No. of Shareholders | 18 | 18 | 1,034 | 584 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Krishnamurthy Ganesan | Shareholding of Promoter and Promoter Group | 21.9% | 51,16,250 |
| Prashant Krishnamurthy | Shareholding of Promoter and Promoter Group | 17.6% | 41,20,875 |
| Lalitha Krishnamurthy | Shareholding of Promoter and Promoter Group | 16.9% | 39,50,875 |
| Pink Tiger Alliances Llp | Public Shareholding | 10.4% | 24,22,200 |
| Kedia Securities Private Limited | Public Shareholding | 4.5% | 10,60,800 |
| Nav Capital Vcc - Nav Capital Emerging Star Fund | Public Shareholding | 2.5% | 5,91,600 |
| Minerva Ventures Fund | Public Shareholding | 2.3% | 5,34,000 |
| Multiplier Share & Stock Advisors Pvt Ltd | Public Shareholding | 1.3% | 3,00,000 |
| Gujrani Foods Private Limited | Public Shareholding | 1.1% | 2,52,000 |
| Gujrani Consultancy Services Private Limited | Public Shareholding | 1.1% | 2,53,200 |
| Navbharat Investment Trust-navbharat Investment Opportunitie | Public Shareholding | 1% | 2,41,200 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Krishnamurthy Ganesan | 0 | 0% | 2026-03-31 |
| Lalitha Krishnamurthy | 0 | 0% | 2026-03-31 |
| Prashant Krishnamurthy | 0 | 0% | 2026-03-31 |
| Navbharat Investment Trust-navbharat Investment Opportunitie | 0 | 0% | 2026-03-31 |
| Nav Capital Vcc - Nav Capital Emerging Star Fund | 0 | 0% | 2026-03-31 |
| Minerva Ventures Fund | 0 | 0% | 2026-03-31 |
| Pink Tiger Alliances Llp | 0 | 0% | 2026-03-31 |
| Kedia Securities Private Limited | 0 | 0% | 2026-03-31 |
| Gujrani Foods Private Limited | 0 | 0% | 2026-03-31 |
| Gujrani Consultancy Services Private Limited | 0 | 0% | 2026-03-31 |
| Multiplier Share & Stock Advisors Pvt Ltd | 0 | 0% | 2026-03-31 |
| Krishnamurthy Ganesan | 0 | 0% | 2025-11-18 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| PRASHANT KRISHNAMURTHY | Executive Director & CFO | 2025 |
| Krishnamurthy Ganesan | Managing Director | 2025 |
| Lalitha Krishnamurthy | Whole-time Director | 2025 |
| CHARUDATTA DIGAMBAR MAYEE | Independent Non Exe. Director | 2025 |
| Gopal Krishna Raju | Independent Non Exe. Director | 2025 |
| SEKHAR KAVASSERI RAJAGOPALAN | Independent Non Exe. Director | 2025 |
| Shilpi Bhardwaj | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 25 | 18 | 18 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 4 | 1 | 5 |
| 2025 | 0 | 0 | 0 | 1 | 0 | 1 |
| 2025 | 0 | 0 | 0 | 3 | 1 | 4 |
Company Information
🌐 www.mahamayalifesciences.com ↗
📍 #DPT-033 Gr Flr Plt #79-80 DLF, Prime Tower F Blo.Okhla Phase1, New Delhi, New Delhi, 110020
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search